Anivive appoints Jim Beaubien to board of directors


The prior Latham & Watkins LLP office managing partner, with extensive background to bolster the business

Anivive Lifesciences, a technology-driven pet pharmaceutical company, has deemed Jim Beaubien, former Latham and Watkins office managing partner, to its board of directors. Beaubien offers over 30 years of P/E, IPO, and M&A experience to the board as Anivive plans for its first institutional capital raise in 2023.

"We are extremely excited about the addition of Jim to our Board," said CEO, Dylan Balsz, in a company release.1 "He was Anivive's first investor and truly understands our business and where we are headed. I am confident that with his experience, the best days for Anivive lie ahead."

Those who will be on the board with Beaubien include Dr Robert Bishop (former president of Allergan); Glenn Stearns (founder of Stearns Lending, star of Discovery Channel's Undercover Billionaire); Dr Lynne Dotti (professor of economics, Chapman University); Dr Scott Whitcup (former EVP, R&D Allergan); Dr David Bruyette (chief medical officer at Anivive); and Dylan Balsz (CEO at Anivive).

"I remember when Dylan first approached me on the idea of repurposing human therapeutics for pets," shared Jim Beaubien, "What he and the team have done has been spectacular. From their conditional FDA approval for a canine lymphoma treatment to their upcoming Valley Fever Vaccine, I am extremely excited to join the board and contribute to the next chapter of the Anivive journey."

While at Latham & Watkins, Beaubien chaired the corporate department and had a significant role in expanding the partnership into the largest law firm worldwide. He was counsel to top Fortune 500 companies, including some of the following: Live Nation, Cerner Corporation, DaVita, Mattel, Health Net, Crown Resorts, Farmer Bros., Kilroy Realty, and Moelis & Co.


Anivive announces former Latham & Watkins LLP office managing partner Jim Beaubien to their board of directors. News release. Anivive Life Sciences. January 9, 2022. Accessed January 9, 2022.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.